Updates are available Correction dated 2020-07-24
Click to view Correction: https://doi.org/10.1038/s42003-020-01135-5
-
Authors
Peille, Anne-Lise
Vuaroqueaux, Vincent https://orcid.org/0000-0001-9120-5332
Wong, Swee-Seong https://orcid.org/0000-0001-9956-4241
Ting, Jason
Klingner, Kerstin
Zeitouni, Bruno
Landesfeind, Manuel
Kim, Woo Ho https://orcid.org/0000-0003-0557-1016
Lee, Hyuk-Joon
Kong, Seong-Ho
Wulur, Isabella
Bray, Steven
Bronsert, Peter https://orcid.org/0000-0001-8558-0347
Zanella, Nina
Donoho, Greg
Yang, Han-Kwang
Fiebig, Heinz-Herbert https://orcid.org/0000-0001-6222-7321
Reinhard, Christoph
Aggarwal, Amit https://orcid.org/0000-0003-4800-4046
- License Information
-
More Information
Article History
Received: 20 November 2019
Accepted: 2 June 2020
First Online: 9 July 2020
Change Date: 17 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-020-01135-5
Competing interests
: N.Z. and K.K. are employed by Charles River Discovery Research Services Germany GmbH (formerly Oncotest). H.-H.F., V.V., and A.-L.P. were employed by Charles River Discovery Research Services Germany GmbH (formerly Oncotest) and are now employed by 4HF Biotec GmbH. S.-S.W. and S.B. were employees and stockholders of Eli Lilly and Company and are now employees of LifeOmic. I.W., J.T., A.A., G.D., and C.R. are stockholders and employees of Eli Lilly and Company. B.Z. and M.L. were employed by Charles River Discovery Research Services Germany GmbH (formerly Oncotest) and are now employed by Sogeti and Evotec International GmbH, respectively. The other authors have no competing interests with the present study.
